ASCO Applauds Congress for Providing Additional $2 Billion in NIH Funding

Statement by Clifford A. Hudis, MD, FACP, FASCO, Chief Executive Officer of the American Society of Clinical Oncology (ASCO)
For immediate release
May 1, 2017


Rachel Martin
(571) 483-1383

"We applaud Congress for its leadership in providing an additional $2 billion in funding for the National Institutes of Health (NIH). This increase reaffirms the United States' longstanding, bipartisan commitment to scientific research, and will reinvigorate the scientific community as it continues to rebuild after a decade of flat funding. It also offers hope to millions of Americans and their families who face a cancer diagnosis every year. 

While we're encouraged by the funding increase in the FY17 bill, we will continue to strongly advocate for robust funding levels for FY18.  Scientific innovation doesn't happen overnight and requires sustained support. ASCO will continue to urge Congress and the Administration to make NIH funding a high priority."  


About ASCO: 

Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents more than 40,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at, explore patient education resources at www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube.